Pathogenesis of glomerulosclerosis: Role of epithelial interactions

Clinical and Experimental Nephrology

Volumn 4, Issue 3, 2000, Pages 173-181

  Nagata, Michio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cell cycle; Cellular lesions; Crescents; Glomerulosclerosis; Parietal epithelial cells; Phenotypic changes; Podocytes; Proliferation; Synechiae

Indexed keywords

CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; EPITHELIUM HYPERPLASIA; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HUMAN; KIDNEY EPITHELIUM; MESANGIUM; NONHUMAN; PATHOGENESIS; PHENOTYPE; PODOCYTE; REVIEW;

EID: 0033783272     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101570070018     Document Type: Review

References (107)

1. Glomerulosclerosis in reflux nephropathy
2. Focal segmental sclerosis or scarred focal proliferative glomerulonephritis?
3. Focal sclerosing glomerulonephropathy: A clinicopathologic study
4. Minimal change nephrotic syndrome-focal sclerosis complex (including IgM nephropathy and diffuse mesangial hypercellularity)
5. The kidney in diabetes
6. Focal glomerulosclerosis in idiopathic membranous glomerulonephritis
7. The many masks of focal segmental glomerulosclerosis
8. Focal segmental glomerulosclerosis in patients with uninephrectomy
9. Primary glomerular diseases
10. The history of renal immunopathology
11. Renal disease. Primary glomerular disease
12. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis
13. The significance of the glomeruli-bound anti-renal basement membrane active antibody as the pathogenetic factor of human chronic glomerulonephritis
14. Glomerular events during the initial phase of rat Masugi nephritis
15. Passive transfer of Heymann nephritis with serum
16. Okabayashi Cellular aspects of rabbit Masugi nephritis III Mesangial changes
17. Glomerular mesangium
18. Focal glomerular sclerosis in nephrotic patients: An electron microscopic study of glomerular podocytes
19. Glomerular podocyte degeneration in human renal disease. An ultrastructural study
20. The role of podocytes in the development of glomerular sclerosis
21. The development of focal segmental glomerulosclerosis in Masugi nephritis is based on progressive podocyte damage
22. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis
23. Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: A podocyte disease
24. Development of vascular pole-associated glomerulosclerosis in the Fawnhooded rat
25. Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat
26. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats
27. Glomerular hyalinosis and its relation to hyperfiltration
28. Glomerular hypertrophy after subtotal nephrectomy: Relationship to early glomerular injury
29. Limitation of podocyte adaptation for glomerular injury in puromycin aminonucleoside nephrosis
30. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes
31. Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study
32. Focal segmental glomerulosclerosis: The cellular lesion
33. Focal segmental glomeurlosclerosis: Prognostic implications of the cellular lesion
34. Structure and development of the glomerular crescent
35. Histogenesis of glomerular crescents. Immunohistochemical demonstration of cytokeratin in crescent cells
36. The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomrulonephritis, and membranoproliferative glomerulonephritis
37. Pathogenesis of glomerular damage in glomerulonephritis
38. Growth factor pathways in proliferative glomerulonephritis
39. Macrophages in childhood IgA nephropathy
40. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group
41. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization
42. Lupus nephritis
43. Reversal of lesions of diabetic nephropathy after pancreas transplantation
44. Experimental mesangioproliferative glomerulonephritis in rats induced by intravenous administration of antithymocyte serum
45. Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture
46. Structure of segmental tuft lesions in childhood IgA nephropathy; three-dimensional analysis indicates development of segmental lesions
47. Chronic Masugi nephritis in the rat. An electron microscopic study on evolution and consequences of glomerular capsular adhesions
48. A frequent pathway to glomerulosclerosis: Deterioration of tuft architecture-podocyte damage-segmental sclerosis
49. Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis
50. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat
51. 3H-thymidine uptake in diabetic and uninephrectomized rats
52. Adaptation and distortion of podocytes in rat remnant kidney
53. Tuft-to-capsule adhesions and their precursors: Differences between the vascular and tubular poles of the human glomerulus
54. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria
55. Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis
56. Podocyte loss and progressive glomerular injury in type II diabetes
57. How does podocyte damage result in tubular damage?
58. Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man
59. Structure and function of podocytes: An update
60. Development of the kidney
61. Expression of intermediate filament proteins in fetal and adult human kidney: Modulation of intermediate filament patterns during development and in damaged tissue
62. Differentiation of epithelial foot processes and filtration slit
63. Loss of mitotic activity and the expression of vimentin in glomerular epithelial cells of developing human kidneys
64. Structure and development of the glomerular capillary wall and basement membrane
65. Podocytes in metanephric organ culture express characteristic in vivo phenotypes
66. Glomerular differentiation in metanephric culture
67. Mice deficient for PDGF-B show renal, cardiovascular, and hematological abnormalities
68. Cell cycle regulation and differentiation in the human podocyte lineage
69. Podocytes in glomerulus of rat kidney express a characteristic 44KD protein
70. Biogenesis of podocalyxin - The major glomerular sialoglycoprotein - In the newborn rat kidney
71. Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developineg glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS
72. Developmental expression of the nephritogenic antigen of monoclonal antibody 5-1-6
73. Localization of olfactomedin-related glycoprotein isoform (BMZ) in the golgi apparatus of glomerular podocytes in rat kidneys
74. Pod-1, a mesodermspecific basic-helix-loop-helix protein expressed in mesenchymal and glomerular epithelial cells in the developing kidney
75. p27kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
76. Cell-cycle contral and renal disease
77. Expression of the cyclin kinase inhibitor, p27Kip1, in developing and mature human kidney
78. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo
79. Polykaryocytosis of the visceral glomerular epithelium in cystinosis with description of an unusual clinical variant
80. Mitosis and presence of binucleate cells among glomerular podocytes in diseased human kidneys
81. Changes in glomerular epithelial cells induced by FGF2 and FGF2 neutralizing antibody in puromycin aminonucleoside nephropathy
82. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy
83. Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis
84. Biomedical aspects of cytokinesis
85. Identification of a major sialoprotein in the glycocalyx of human visceral epithelial cells
86. Synaptopodin: An actin-associated protein in telencephalic dendrites and renal podocytes
87. GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase. Identification, molecular cloning, and characterization in rabbit
88. Phenotypical characteristics and cyclin dependent kinase inhibitor suppression in hyperplastic epithelial pathology in idiopathic focal segmental glomerulosclerosis
89. Cellular and non-cellular compositions of crescents in human glomerulonephritis
90. Glomerular expression of cell cycle regulatory proteins in human crescentic glomerulonephritis
91. Glomerular epithelial protein I and podocalyxin-like protein 1 in inflammatory glomerular disease (crescentic nephritis) in rabbit and man
92. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing ideopatic focal segmental glomerulosclerosis and HIV-associated nephropathy
93. Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis
94. Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy
95. Origin of hyperplastic epithelial cells in idiopathic collapsing glomerulopathy
96. Podocyte detachment and epithelial cell reaction in focal segmental glomerulosclerosis with cellular variants
97. The regeneration of salamander limbs and the retention of the proximal-distal axis
98. Dedifferentiation of low-grade chondrosarcoma
99. Soft tissue tumors
100. Macrophagic cells outgrowth from normal rat glomerular culture: Possible metaplastic change from podocytes
101. Podocytes undergo phenotypic changes and express macrophage associated markers in idiopathic collapsing glomerulopathy
102. Tissue repair: Cellular growth, fibrosis and wound healing
103. Progression of renal disease
104. Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis
105. The ultrastructural organization of the basement membrane of Bowman's capsule in the rat renal corpuscle
106. Collagen distribution in focal and segmental glomerulosclerosis: An immunofluorescence and ultrastructural immunogold study